Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Conditions:   Hepatocellular Carcinoma;   Portal Vein Tumor Thrombus;   Liver Transplantation Interventions:   Drug: lenvatinib;   Drug: Placebo Sponsor:   RenJi Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials